Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · Real-Time Price · USD
18.44
-0.65 (-3.40%)
At close: Jul 24, 2026, 4:00 PM EDT
18.19
-0.25 (-1.38%)
After-hours: Jul 24, 2026, 7:36 PM EDT
Relay Therapeutics Market Cap
Relay Therapeutics has a market cap or net worth of $4.02 billion as of July 24, 2026. Its market cap has increased by 518.49% in one year.
Market Cap
4.02B
Enterprise Value
3.41B
1-Year Change
518.49%
Ranking
Category
Stock Price
$18.44
ChartMarket Cap Chart
Since July 16, 2020, Relay Therapeutics's market cap has increased from $3.03B to $4.02B, an increase of 32.42%. That is a compound annual growth rate of 4.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 24, 2026 | 4.02B | 174.08% |
| Dec 31, 2025 | 1.47B | 112.63% |
| Dec 31, 2024 | 689.62M | -49.19% |
| Dec 29, 2023 | 1.36B | -24.86% |
| Dec 30, 2022 | 1.81B | -45.57% |
| Dec 31, 2021 | 3.32B | -11.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Jul 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Legend Biotech | 4.39B |
| Caris Life Sciences | 4.33B |
| Edgewise Therapeutics | 4.26B |
| ACADIA Pharmaceuticals | 4.25B |
| Celcuity | 4.19B |
| Viking Therapeutics | 4.09B |
| Parabilis Medicines | 4.06B |
| Dyne Therapeutics | 4.00B |